Carrick Therapeutics, Inc.

A solid portfolio, backed by good science

In order to have the greatest impact on patient lives, we translate in-house and in-licensed assets to target the most aggressive and resistant forms of cancer. Together with our Pharma partners, network of clinicians and scientists across research institutions and hospitals, we are developing ground-breaking cancer therapies.

Building the next generation of advanced cancer therapies

Novel therapies to address unmet patient needs

Our therapies work in combination with existing oncology drugs to target advanced breast, prostate and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma.